The setup: MediciNova, Inc. (MNOV) has a Phase 2B trial for MN-166, ibudilast, indicated for progressive multiple sclerosis. The data will be released Oct. 28 at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting. Typically, there’s a really nice run-up for companies that have later-stage trial results for a major disease like MS coming out on a specific date.
The back story: MediciNova is a low-float stock that doesn’t trade much, so you have to be careful. It has a market cap of just $20.67 million, so it’s not very liquid, which can be risky. On Thursday, trading volume was just shy of 150,000 shares, but that was a high-volume day; the average is closer to 50,000 shares traded per day.
How I’m playing it/what I’m looking for: I already have 1,000 shares purchased Sept. 6 at $5.22. As of Thursday’s close, MNOV is at $5.88. I’d be looking to add to the position, buying on the dips, but only if it retraces to $5.50 or so. I’m planning on holding Medicinova at least until it hits $6.50 or gets within a week or two of that data release in late October.
Kyle Dennis runs Kyle Dennis’ Biotech Breakouts (biotechbreakouts.com). He is an event-based trader, who prefers low-priced and small-cap biotech stocks. He currently holds 1,000 shares in MNOV, purchased Sept. 6 at $5.22 per share; he has no options or open orders in the stock.
You may also like
Exclusive System Tracks Wall St. Insiders
“Dollar Ace Simply Exposes Information That Wall Street Wants To Keep Quiet” Said Kyle Dennis
“One member, Wesley M., has already reported 360%+ gains in just a few short days. Don’t miss this!”
(Reserve Access Now)
“What Recession?!” Jason Bond nets $55,060 in realized profit in One Day
After going 6 for 6 on profitable trades recently, we caught up with Jason to ask how he did it.
Check out Jason’s exclusive interview revealing this tightly guarded strategy. (Watch Now)
RagingBull.com Co-Founder, Jeff Bishop, Launches High Conviction Trade Service
“We listen to our clients and we give them EXACTLY what they want, so we designed a service to deliver 1 trade, 1 time a week, with a 100%+ PROFIT TARGET, directly to your inbox every Monday before the market opens. (Read More)